Bannerji, Rajat <br/><br/>
Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2003 
 - 1466-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2003.06.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>CD55 Antigens--metabolism<br/>CD59 Antigens--metabolism<br/>Complement System Proteins--drug effects<br/>Drug Resistance, Neoplasm<br/>Flow Cytometry<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunoblotting<br/>Leukemia, Lymphocytic, Chronic, B-Cell--immunology<br/>Multicenter Studies as Topic<br/>Myeloid Cell Leukemia Sequence 1 Protein<br/>Neoplasm Proteins--metabolism<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Rituximab<br/>Treatment Outcome<br/>bcl-2-Associated X Protein